Co-treatment of Nimbolide augmented the anti-arthritic effects of methotrexate while protecting against organ toxicities

Development of nanozymes for promising alleviation of COVID-19-associated arthritis

“…87 Some antiarthritic and anti-inflammatory drugs have been used to regulate ROS, inflammatory factors, and other symptoms of arthritis. [88][89][90] However, the majority of these drugs have potential side effects, [91][92][93] and are not suitable for COVID-19 patients, who may experience long-term debilitating symptoms such as insomnia, rapid heartbeat, and fatigue. Compared to traditional anti-inflammatory drugs and ROS scavengers, these 53 Copyright 2021, Elsevier.…”